news
Here you will find the latest news on Lamisil AT and Lamisil Once ®
European experts convene to address non-compliance in the treatment of athlete's foot
2006-09-03
Non-compliance is a major issue as treatment instructions are frequently not followed. Single-dose formulation reduces the risk of non-compliance and may improve public health. Need for further patients and pharmacists education on the disease.
Contains terbinafine. Always read the label.
